Lung Cancer Awareness Month: Beyond Blame, Toward Understanding

The question nobody asks about other cancers

November is Lung Cancer Awareness Month. It exists partly because of a question people with this diagnosis get asked constantly and people with other cancers almost never do: did you smoke?

The question is not neutral. It sorts patients into deserving and undeserving before anyone has looked at a scan. It makes people delay going to a doctor about a cough. And it has almost nothing to do with how the disease is treated.

So this page skips it and goes to the medicine.

What the disease actually is

Lung cancer divides into two groups, and the split governs treatment far more than any biographical detail.

Non-small cell lung cancer is the larger group. Within it sit adenocarcinoma, which starts in cells lining the small air sacs; squamous cell carcinoma, which starts in the flat cells lining the airways; and large cell carcinoma.

Small cell lung cancer grows and spreads faster and is usually treated with chemotherapy and radiation rather than surgery.

For advanced non-small cell disease there is now a second layer. NCI's clinical summary describes testing tumors for specific gene changes — EGFR, ALK, ROS1, BRAF, MET and others — and for a protein called PD-L1. Those results decide whether someone is offered a targeted tablet, immunotherapy, chemotherapy, or a combination. Two people with the same stage on the same scan can end up on entirely different treatments.

That testing is the single most useful thing to ask about after a diagnosis of advanced lung cancer. Our overview of lung cancer explains what it involves.

Who gets it

NCI's prevention summary is blunt about tobacco. Smoking cigarettes causes about 9 out of 10 cases of lung cancer in men and about 8 out of 10 in women, and people who smoke carry about 20 times the risk of people who do not.

The same summary rules out two comforting beliefs. Low-tar and low-nicotine cigarettes do not lower the risk. And risk rises with both the number of cigarettes smoked per day and the number of years smoked, so cutting down is not the same as stopping.

But read those figures again from the other end. One in ten cases in men and two in ten in women are not caused by smoking. NCI also names secondhand smoke, radon in the home, workplace exposure to asbestos and certain metals, air pollution, and family history.

People who have never smoked get lung cancer. They are often younger, and their symptoms are more likely to be attributed to asthma, allergies, or a lingering virus — which is one way stigma costs time.

When to get checked

Bring any of these to a clinician if it has lasted more than about three weeks, whether or not you have ever smoked:

• A cough that will not clear up, or a long-standing cough that has changed in sound or frequency.
• Coughing up blood, even a streak, even once.
• Breathlessness doing things that used to be easy.
• Chest, shoulder, or back pain present at rest rather than only on movement.
• A hoarse voice with no sore throat behind it.
• Chest infections that keep returning to the same spot.
• Unexplained weight loss or fatigue.

None of these means cancer. A chest x-ray and a conversation usually settle it. The reason to go early is that stage at diagnosis is the single largest factor in what happens next.

What screening does, and who it is for

Screening means testing people with no symptoms at all. For lung cancer the test is a low-dose CT scan, and NCI reports it has been shown to lower the risk of dying from lung cancer in heavy smokers.

The evidence came from the National Lung Screening Trial. NCI describes who it enrolled: people aged 55 to 74 who had smoked at least a pack a day for 30 years or more, either current smokers or people who had quit within the previous 15 years. Annual low-dose CT for three years found early cancers better than chest x-ray.

Screening also has costs. Scans find spots that are not cancer, and each one leads to more scans or a biopsy. Some cancers found would never have caused harm. And the scans deliver radiation.

Because the benefit depends on how likely a cancer is in the first place, eligibility is defined by smoking history and age. Whether it applies to you is worked out with a clinician rather than looked up. Our page on cancer screening explains how benefit and harm are weighed generally.

The scale of it

The American Cancer Society estimates about 229,410 new lung and bronchus cancers in the United States in 2026 and about 124,990 deaths; SEER, a surveillance program at the National Cancer Institute, carries that projection alongside its own measurements. That is 20.0% of all cancer deaths — the largest share of any cancer. The median age at diagnosis is 71.

Stage drives outcome. Among people diagnosed from 2016 through 2022, about 24% of cases are found while still confined to the lung, and five-year relative survival for that group is 65.5%. It falls to 38.2% once the cancer has reached nearby lymph nodes and 10.5% once it has spread further. Fully 51% are found at that distant stage. Across all stages it is 29.5%.

Those are group averages from people diagnosed years ago, many of them before targeted therapy and immunotherapy were routine. They describe a population, not a person, and they are not a prediction for anyone.

What this does not mean

Awareness months do not change biology, and this one has a specific job: getting people to a doctor sooner. Every extra week spent deciding whether a cough is worth mentioning is a week the stage distribution above gets worse.

Nor does the smoking statistic justify the question. Whether someone smoked changes nothing about their treatment, their prognosis, or what they are owed. It is not a clinical variable in the way people imagine.

And prevention is not a moral score. Our page on cancer prevention covers what actually lowers risk across a population, which is a different thing from explaining any one person's cancer.

Sources

• NCI PDQ: Lung Cancer Prevention (Patient Version)
• NCI PDQ: Lung Cancer Screening (Patient Version)
• NCI PDQ: Non-Small Cell Lung Cancer Treatment (Health Professional Version)
• NCI SEER Cancer Stat Facts: Lung and Bronchus Cancer

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.